(Q35261440)

7 August 2017

Pomegranate phenolics inhibit formation of advanced glycation endproducts by scavenging reactive carbonyl species (English)

1 reference

7 August 2017

6

Navindra P Seeram

1 reference

7 August 2017

Weixi Liu

1

1 reference

7 August 2017

Hang Ma

2

1 reference

7 August 2017

Leslie Frost

3

1 reference

7 August 2017

Tao Yuan

4

1 reference

7 August 2017

Joel A Dain

5

1 reference

7 August 2017

1 November 2014

1 reference

7 August 2017

1 reference

7 August 2017

5

1 reference

7 August 2017

11

1 reference

7 August 2017

2996-3004

1 reference

The AGE of the matrix: chemistry, consequence and cure

7 August 2017

1 reference

https://api.crossref.org/works/10.1039%2FC4FO00538D

Maillard reaction products in tissue proteins: new products and new perspectives

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC4FO00538D

Protein glycation, diabetes, and aging

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC4FO00538D

Hyperglycemia and glycation in diabetic complications.

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC4FO00538D

RAGE and amyloid-beta peptide neurotoxicity in Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC4FO00538D

Advanced glycation endproducts and their receptor RAGE in Alzheimer's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC4FO00538D

Maillard reaction-mediated molecular damage to extracellular matrix and other tissue proteins in diabetes, aging, and uremia

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC4FO00538D

Advanced glycation end products in Alzheimer's disease and other neurodegenerative diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC4FO00538D

The induction of surface beta-amyloid binding proteins and enhanced cytotoxicity in cultured PC-12 and IMR-32 cells by advanced glycation end products

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC4FO00538D

Possible involvement of advanced glycation end-products (AGEs) in the pathogenesis of Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC4FO00538D

Carbonyl toxicology and Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC4FO00538D

The road to advanced glycation end products: a mechanistic perspective.

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC4FO00538D

Non-enzymatic glycation of melamine with sugars and sugar like compounds.

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC4FO00538D

Characterization of advanced glycation end products for biochemical studies: side chain modifications and fluorescence characteristics

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC4FO00538D

Use of aminoguanidine (Pimagedine) to prevent the formation of advanced glycation endproducts

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC4FO00538D

Naturally occurring inhibitors against the formation of advanced glycation end-products

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC4FO00538D

Inhibition of advanced glycation endproduct formation by foodstuffs

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC4FO00538D

Antioxidant activity of pomegranate juice and its relationship with phenolic composition and processing

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC4FO00538D

Pomegranate juice, total pomegranate ellagitannins, and punicalagin suppress inflammatory cell signaling in colon cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC4FO00538D

Anti-oxidative effects of pomegranate juice (PJ) consumption by diabetic patients on serum and on macrophages

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC4FO00538D

Pomegranate juice decreases amyloid load and improves behavior in a mouse model of Alzheimer's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC4FO00538D

Pomegranate polyphenols and extract inhibit nuclear factor of activated T-cell activity and microglial activation in vitro and in a transgenic mouse model of Alzheimer disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC4FO00538D

Inhibition of nonenzymatic protein glycation by pomegranate and other fruit juices

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC4FO00538D

The potent in vitro antioxidant ellagitannins from pomegranate juice are metabolised into bioavailable but poor antioxidant hydroxy-6H-dibenzopyran-6-one derivatives by the colonic microflora of healthy humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC4FO00538D

Pomegranate juice and extracts provide similar levels of plasma and urinary ellagitannin metabolites in human subjects

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC4FO00538D

Absorption, metabolism, and antioxidant effects of pomegranate (Punica granatum l.) polyphenols after ingestion of a standardized extract in healthy human volunteers

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC4FO00538D

Biological significance of urolithins, the gut microbial ellagic Acid-derived metabolites: the evidence so far

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC4FO00538D

Antiglycative and neuroprotective activity of colon-derived polyphenol catabolites

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC4FO00538D

Inhibitory effects of polyphenol punicalagin on type-II collagen degradation in vitro and inflammation in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC4FO00538D

Characterization of advanced glycation end products: mass changes in correlation to side chain modifications.

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC4FO00538D

End-stage renal disease and diabetes catalyze the formation of a pentose-derived crosslink from aging human collagen

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC4FO00538D

21 January 2018

Identifiers

DOI

10.1039/C4FO00538D

1 reference

7 August 2017

1 reference